A preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases; the company's refined drug discovery approach purportedly saves as much as 3 years in drug development and increases success rates 30X vs. traditional methods. Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.